NanJing Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
NanJing Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, NanJing Pharmaceutical Co Ltd (600713) has a cash flow conversion efficiency ratio of -0.119x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-942.93 Million ≈ $-137.98 Million USD) by net assets (CN¥7.95 Billion ≈ $1.16 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of NanJing Pharmaceutical Co Ltd (1998–2024)
Cash flow conversion efficiency of NanJing Pharmaceutical Co Ltd from 1998 to 2024. This chart illustrates how NanJing Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NanJing Pharmaceutical Co Ltd (600713) share price today for real-time trading data and today's change.
NanJing Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
NanJing Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
NanJing Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NanJing Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see market cap of NanJing Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tianjin Capital Environmental Protection Group Co Ltd
SHG:600874
|
0.238x |
|
Jupiter Life Line Hospitals Limited
NSE:JLHL
|
0.084x |
|
Gosuncn Technology Group Co Ltd Class A
SHE:300098
|
0.024x |
|
Suzhou Medsys Tech Co Ltd
SHG:603990
|
0.062x |
|
Cargojet Inc
TO:CJT
|
0.131x |
|
Pacira BioSciences, Inc.
NASDAQ:PCRX
|
0.086x |
|
Hartalega Holdings Bhd
KLSE:5168
|
0.013x |
|
Resolute Holdings Management, Inc.
NYSE:RHLD
|
0.031x |
Annual Cash Flow Conversion Efficiency for NanJing Pharmaceutical Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of NanJing Pharmaceutical Co Ltd from 1998 to 2024. Review free cash flow generation of NanJing Pharmaceutical Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥7.79 Billion ≈ $1.14 Billion |
CN¥2.14 Billion ≈ $312.53 Million |
0.274x | +4.36% |
| 2023-12-31 | CN¥7.25 Billion ≈ $1.06 Billion |
CN¥1.91 Billion ≈ $278.97 Million |
0.263x | +357.83% |
| 2022-12-31 | CN¥6.69 Billion ≈ $979.67 Million |
CN¥-682.31 Million ≈ $-99.84 Million |
-0.102x | -176.71% |
| 2021-12-31 | CN¥5.23 Billion ≈ $765.86 Million |
CN¥695.33 Million ≈ $101.75 Million |
0.133x | +155.57% |
| 2020-12-31 | CN¥4.82 Billion ≈ $705.34 Million |
CN¥-1.15 Billion ≈ $-168.64 Million |
-0.239x | -207.64% |
| 2019-12-31 | CN¥4.52 Billion ≈ $661.42 Million |
CN¥1.00 Billion ≈ $146.91 Million |
0.222x | +348.76% |
| 2018-12-31 | CN¥4.11 Billion ≈ $601.30 Million |
CN¥-366.90 Million ≈ $-53.69 Million |
-0.089x | -188.92% |
| 2017-12-31 | CN¥3.19 Billion ≈ $466.29 Million |
CN¥319.99 Million ≈ $46.82 Million |
0.100x | +227.96% |
| 2016-12-31 | CN¥3.07 Billion ≈ $449.14 Million |
CN¥-240.88 Million ≈ $-35.25 Million |
-0.078x | +31.12% |
| 2015-12-31 | CN¥2.69 Billion ≈ $393.13 Million |
CN¥-306.08 Million ≈ $-44.79 Million |
-0.114x | +18.57% |
| 2014-12-31 | CN¥2.44 Billion ≈ $356.66 Million |
CN¥-341.01 Million ≈ $-49.90 Million |
-0.140x | +49.13% |
| 2013-12-31 | CN¥1.29 Billion ≈ $188.48 Million |
CN¥-354.27 Million ≈ $-51.84 Million |
-0.275x | -314.86% |
| 2012-12-31 | CN¥1.31 Billion ≈ $192.23 Million |
CN¥168.17 Million ≈ $24.61 Million |
0.128x | +125.10% |
| 2011-12-31 | CN¥1.36 Billion ≈ $198.74 Million |
CN¥-692.53 Million ≈ $-101.34 Million |
-0.510x | -641.23% |
| 2010-12-31 | CN¥1.26 Billion ≈ $184.95 Million |
CN¥119.08 Million ≈ $17.42 Million |
0.094x | +247.07% |
| 2009-12-31 | CN¥744.78 Million ≈ $108.98 Million |
CN¥20.22 Million ≈ $2.96 Million |
0.027x | +283.11% |
| 2008-12-31 | CN¥610.69 Million ≈ $89.36 Million |
CN¥4.33 Million ≈ $633.18K |
0.007x | -93.87% |
| 2007-12-31 | CN¥700.93 Million ≈ $102.57 Million |
CN¥81.08 Million ≈ $11.86 Million |
0.116x | -53.82% |
| 2006-12-31 | CN¥643.97 Million ≈ $94.23 Million |
CN¥161.31 Million ≈ $23.61 Million |
0.250x | -2.12% |
| 2005-12-31 | CN¥646.94 Million ≈ $94.67 Million |
CN¥165.57 Million ≈ $24.23 Million |
0.256x | +866.48% |
| 2004-12-31 | CN¥614.14 Million ≈ $89.87 Million |
CN¥16.26 Million ≈ $2.38 Million |
0.026x | -15.90% |
| 2003-12-31 | CN¥611.84 Million ≈ $89.53 Million |
CN¥19.27 Million ≈ $2.82 Million |
0.031x | -76.86% |
| 2002-12-31 | CN¥505.29 Million ≈ $73.94 Million |
CN¥68.75 Million ≈ $10.06 Million |
0.136x | +1628.15% |
| 2001-12-31 | CN¥472.04 Million ≈ $69.07 Million |
CN¥-4.20 Million ≈ $-615.03K |
-0.009x | -104.94% |
| 2000-12-31 | CN¥486.93 Million ≈ $71.25 Million |
CN¥87.68 Million ≈ $12.83 Million |
0.180x | +58.29% |
| 1999-12-31 | CN¥444.61 Million ≈ $65.06 Million |
CN¥50.58 Million ≈ $7.40 Million |
0.114x | -37.30% |
| 1998-12-31 | CN¥426.92 Million ≈ $62.47 Million |
CN¥77.45 Million ≈ $11.33 Million |
0.181x | -- |
About NanJing Pharmaceutical Co Ltd
Nanjing Pharmaceutical Group Company Limited engages in the drug distribution businesses in China. It also involved in the wholesale and retail of medical device distribution; pharmaceutical logistics; and internet drug retail business. The company was formerly known as NanJing Pharmaceutical Company Limited and change its name to Nanjing Pharmaceutical Group Company Limited in December 2025. Nan… Read more